Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX8OSS
|
||||
| Drug Name |
1-(2-bromophenyl)-3-{19-methyl-14-oxo-3-propyl-3,13,19,20-tetraazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,21}]tricosa-1(16),2(10),4,6,8,11(15),17,20-octaen-7-yl}urea
|
||||
| Synonyms |
CHEMBL375570
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C30H27BrN6O2
|
||||
| Canonical SMILES |
CCCn1c2ccc(NC(=O)Nc3ccccc3Br)cc2c4c5CNC(=O)c5c6c(CCc7nn(C)cc67)c14
|
||||
| InChI |
InChI=1S/C30H27BrN6O2/c1-3-12-37-24-11-8-16(33-30(39)34-23-7-5-4-6-21(23)31)13-18(24)26-19-14-32-29(38)27(19)25-17(28(26)37)9-10-22-20(25)15-36(2)35-22/h4-8,11,13,15H,3,9-10,12,14H2,1-2H3,(H,32,38)(H2,33,34,39)
|
||||
| InChIKey |
UQTLOZLAWRMFSV-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.